Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
601 participants
OBSERVATIONAL
2011-01-31
2012-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.
NCT02770079
Follow up Glucose Levels Among Infants of Diabetic Mothers
NCT00337142
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
NCT06643351
Severe Hypoglycemia in Pregnant Women With Type 1 Diabetes
NCT00435565
Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus
NCT02596932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Management of these pregnancies depends on whether these women have pre-gestational or gestational diabetes. Very few diabetic women have exposure to preconceptual advice. For this reason we opted to find out the outcome of infants of diabetic mothers compared to those mothers who are essentially normal with no associated medical or obstetric disorders. Equally we wanted to see if there are differences in the outcome of infants born to pre-gestational and gestational diabetic mothers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prevention of complications in infants of diabetic mothers
strict glycemic control in diabetic pregnancies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Hour
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Security Forces Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
OMER B ABDELBASIT
Consultant Neonatolgist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABEER E LASHEEN, MBBS
Role: STUDY_DIRECTOR
Security Forces Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Security Forces Hospital
Riyadh, Central, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alqurashi KA, Aljabri KS, Bokhari SA. Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med. 2011 Jan-Feb;31(1):19-23. doi: 10.4103/0256-4947.75773.
Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study. Diabetes Care. 2009 Nov;32(11):2005-9. doi: 10.2337/dc09-0656. Epub 2009 Aug 12.
Yang J, Cummings EA, O'connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006 Sep;108(3 Pt 1):644-50. doi: 10.1097/01.AOG.0000231688.08263.47.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OJS2817
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.